Varicose Veins Treatment Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029

Varicose veins treatment devices market to exhibit dynamic growth during the forecast period

The global varicose veins treatment devices market is increasing proficiently, expected to grow at a CAGR of 6.5%. Worldwide, the increasing burden of varicose veins along with improved therapeutic treatment options will drive the market growth. Around 40 million people in the U.S. suffer from varicose veins. Growing awareness about new sclerotherapy procedures, laser technology, and minimally invasive procedures to overcome the limitations by traditional procedures will increase the demand for advanced devices. Key factors such as increased expansion and acceptance for enzyme replacement therapy in the emerging nations, rising geriatric population, and U.S. FDA approvals for varicose veins treatment products will drive the overall market growth on a global scale.

Ablation devices expected to register higher growth by the end of 2029

Advancement in radiofrequency ablation devices with enhanced biocompatibility will drive market growth. Novel applications for endovenous laser therapy among the patients as a standard treatment option will drive the market growth. For e.g. market approval of polidocanol endovenous microfoam (Varithena, BTG). In January 2019, Varithena (polidocanol injectable foam) was approved in the Canadian market for the treatment of incompetent great saphenous veins. Additionally, greater awareness and enhanced therapy launch in the outpatient centers and clinics for various varicose veins and chronic venous insufficiency procedures will boost the market growth in the developed nations. For e.g. Venefit™ procedure. Moreover, the new launch of devices and surgical products such as VenaSeal Closure System, Purespume (pipeline), VBOX hybrid, laser instruments, and other injection sclerotherapy products will further spur revenue growth in the near future.

Endovenous thermal ablation to witness a significant CAGR

Preference for thermal ablation minimally invasive procedures (also known as radiofrequency ablation or laser therapy) in the developed nations show promising growth. Moreover, advancement in non-thermal ablation such as Clarivein treatment (ClariVein® infusion catheter) will drive the market growth. Advancement in microphlebectomy, ultrasound-guided foam sclerotherapy, microsclerotherapy, high ligation and stripping will further spur revenue growth during the forecast period. For e.g. Advancement in new Echotherapy technology (by Theraclion) show progressive growth for varicose veins treatment and venous ulcers. It is a non-invasive ablation therapy delivered by SONOVEIN® system, allows treatment without chemical injections, catheters, or incisions.

Increased research and development with strong product pipelines in the developed regions

Major players in the varicose veins treatment market are Medtronic plc, biolitec AG, Syneron Medical Ltd., Lumenis Ltd., Energist Group, AngioDynamics, Inc., Vascular Solutions, Inc., Quanta System S.p.A., Eufoton s.r.l., Sciton, Inc., Dornier MedTech GmbH, Miravas, BTG plc, Sciton, Inc., Merz Pharma GmbH & Co. KGaA, Fotona d.o.o., and others. Major players are developing new technology with collective biological solutions along with sclerotherapy, laser surgery, endovenous ablation therapy, ambulatory phlebectomy, vein surgery and others. New product launch, acquisitions, partnerships with hospitals, technology expansion in developing nations along with improved R&D on varicose veins treatment devices will drive the market growth during the forecast period.

Historical & Forecast Period

This study report represents analysis for each segment from 2019 to 2029 considering 2020 to be the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period from 2021 to 2029.

The current report also comprehends qualitative and qualitative market valuation factors such as key market drivers, market trends, restraints and opportunities that gives a better market understanding of the overall varicose veins treatment devices market. Additionally, the global report also comprises graphical representation of competitive landscape based on their market initiatives and strategies, product portfolio and business strengths.

Key questions answered in this report

• What are the current market trends and dynamics in the varicose veins treatment devices market and valuable opportunities for emerging players?
• Which segment accounts for the fastest CAGR during the forecast period and why?
• Which product type segment holds a larger market share and why?
• Are low and middle-income economies investing in the varicose veins treatment devices market?
• What is the market trend and dynamics in emerging markets such as Asia Pacific, Latin America and Middle East & Africa?

This product will be delivered within 2 business days.